Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy

PURPOSE: The phosphoinositide-3-kinase (PI3K), phosphatase and tensin homolog (PTEN), v-akt murine thymoma viral oncogene homolog (AKT), and mammalian target of rapamycin (mTOR) signaling pathway has been implicated in resistance to several chemotherapeutic agents. In this retrospective study, we de...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hildebrandt, Michelle A.T., Yang, Hushan, Hung, Mien-Chie, Izzo, Julie G., Huang, Maosheng, Lin, Jie, Ajani, Jaffer A., Wu, Xifeng
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2009
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738430/
https://ncbi.nlm.nih.gov/pubmed/19164214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.6297
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires